Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis
NCT ID: NCT03948750
Last Updated: 2019-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2010-01-01
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
NCT02843438
Pregnancy and Congenital Toxoplasmosis
NCT05774496
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
NCT01449877
Lyon Cohort of Maternal and Congenital Toxoplasma Infections
NCT02936921
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
NCT04825600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in aqueous humour/Total IgG in serum)
0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody production, \> 4: Diagnostic of intraocular antibody production to a specific microbial pathogen
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Ocular Toxoplasmosis
Aqueous humour sampling
Aqueous humour sampling with Goldman-Witmer coefficient and immunoblotting
Patients without Ocular Toxoplasmosis
Aqueous humour sampling
Aqueous humour sampling with Goldman-Witmer coefficient and immunoblotting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aqueous humour sampling
Aqueous humour sampling with Goldman-Witmer coefficient and immunoblotting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service d'ophtalmologie, Hôpital de la Croix-Rousse (HCL)
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COPILOT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.